|Title:||Bisphosphonates in primary attention. Study epidemiologist of administration and repercussion of bisphosphonates in patientes who they go to consultations of odontology of the Canary Service of Health||Authors:||Bocanegra-Pérez, S.
Limiñana-Cañal, J. M.
Gayá Miquel, B.
|Issue Date:||2010||Publisher:||0213-1285||Journal:||Avances en odontoestomatologia||Abstract:||Objetives: We have realized a study in three consutations of Odontology of Las Palmas of Gran Canaria, to know the percentage patients that goes to the same in tratment with bisphosphonates (BF), what characteristic has, what benefits they request and if these medicaments determine the dental treatments. Equally, we want to know the degree of information about the possible side effects of the administration of BF in relation to the oral health and if previous revisions were carried out to this treatment. Design of the study: Surveys were realised during 40 labour days (between the months June and July, 2007) to all the 50-year-old patients o more, that they came with appointment before the Consultations of Odontology of three Centers of Health, of the Canary Service of Health in Las Palmas of Gran Canaria. Results: Of 501patients, 25 (5%) was in treatment with BF. The risedronato and the alendronato were the most used BF. One found minor frequency of exodoncias with regard to waited in these patients and an increase of the medicinal prescriptions. Conclusions: No patient had come for dental review before initiating a treatment with BF. The patientes in treatment with BF oral route are not properly informed about the possibility of osteonecrosis maxillary after any dental manipulation.||URI:||http://hdl.handle.net/10553/49246||ISSN:||0213-1285||Source:||Avances en Odontoestomatologia[ISSN 0213-1285],v. 26, p. 143-151|
|Appears in Collections:||Artículos|
checked on Sep 12, 2021
checked on Aug 1, 2021
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.